A cross-sectional investigation of biomarkers of risk after a decade of smoking

References

• Ames, B.N. 1989. Endogenous oxidative DNA damage, aging, and cancer. Free Radical Res. Commun. 7:121–128.
   PubMedGoogle Scholar
• Barr, D.B., Wang, R.Y., Needham, L.L. 2005a. Biologic monitoring of exposure to environmental chemicals throughout the life stages: Requirements and issues for consideration for the National Children’s Study. Environ. Health Perspect. 113:1083–1091.
   PubMed Web of Science ®Google Scholar
• Barr, D.B., Wilder, L.C., Caudill, S.P., Gonzalez, A.J., Needham, L.L., Pirkle, J.L. 2005b. Urinary creatinine concentrations in the U.S. population: Implications for urinary biologic monitoring measurements. Environ. Health Perspect. 113:192–200.
   PubMed Web of Science ®Google Scholar
• Borland, C., Chamberlain, A., Higenbottam, T., Shipley, M., Rose, G. 1983. Carbon monoxide yield of cigarettes and its relation to cardiorespiratory disease. Br. Med. J. 287:1583–1586.
   PubMedGoogle Scholar
• Burns, D. 2003. Epidemiology of smoking-induced cardiovascular disease. Prog. Cardiovasc. Dis. 46:11–29.
   PubMed Web of Science ®Google Scholar
• Calapai, G., Caputi, A.P., Mannucci, C., Russo, G.A, Gregg, E., Puntoni, R., Lowe, F., Bassi, A., Morandi, S., Nunziata, A. 2009. Cardiovascular biomarkers in groups of established smokers after a decade of smoking. Basic Clin. Pharmacol. Toxicol. 104:322–328.
   PubMed Web of Science ®Google Scholar
• Eberhardt, M., Powell, A., Bonfante, G., Rupp, V., Guarnaccia, J.R., Heller, M., Reed, J. 2006. Non invasive measurement of carbon monoxide levels in ED patients with headhache. J. Med. Toxicol. 2(3):89–92.
   PubMedGoogle Scholar
• Freedman, D.S., Flanders, W.D., Barboriak, J.J., Malarcher, A.M., Gates, L. 1996. Cigarette smoking and leukocyte subpopulations in men. Ann. Epidemiol. 6:299–306.
   PubMed Web of Science ®Google Scholar
• Gregg, E.O., Fisher, A.L., Lowe, F., McEwan, M., Massey, E.D. 2006. An approach to the validation of biomarkers of harm for use in a tobacco context. Regul. Toxicol. Pharmacol. 44:262–267.
   PubMed Web of Science ®Google Scholar
• Gunsolley, J.C., Pandey, J.P., Quinn, S.M., Tew, J., Schenkein, H.A. 1997. The effect of race, smoking and immunoglobulin allotypes on IgG subclass concentrations. J. Periodontal. Res. 32:381–387.
   PubMed Web of Science ®Google Scholar
• Hatsukami, D.K., Benowitz, N.L., Rennard, S.I., Oncken, C., Hecht, S.S. 2006. Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tobacco Res. 8:600–622.
   PubMed Web of Science ®Google Scholar
• Hatsukami, D.K., Hecht, S.S., Hennrikus, D.J., Joseph, A.M., Pentel, P.R. 2003. Biomarkers of tobacco exposure or harm: Application to clinical and epidemiological studies. Nicotine Tobacco Res. 5(3):387–396.
   PubMedGoogle Scholar
• Inoue, O., Seiji, K., Takahashi, M., Kudo, K., Nakatsuka, H., Watanabe, T., Uchida, Y., Ikeda, M. 1995. Subtle increase in leukocyte counts in association with drinking and smoking habits. Int. Arch. Occup. Environ. Health 66:383–388.
   PubMedGoogle Scholar
• Javors, M.A., Hatch, J.P., Lamb, R.J. 2005. Cut-off levels for breath carbon monoxide as a marker for cigarette smoking. Addiction 100(2):159–167.
   PubMedGoogle Scholar
• Jensen, L.E., Whithehead, A.S. 1998. Regulation of serum amyloid A protein expression during acute-phase response. Biochem. J. 334:489–503.
   PubMed Web of Science ®Google Scholar
• McMillan, S.A., Douglas, J.P., Archbold, G.P., McCrum, E.E., Evans, A.E. 1997. Effect of low to moderate levels of smoking and alcohol consumption on serum immunoglobulin concentrations. J. Clin. Pathol. 50:819–822.
   PubMed Web of Science ®Google Scholar
• Morrow, J., Hill, K., Burk, R., Nammour, T.M., Badr, K.F., Roberts, L.J. 1990. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase free radical catalysed mechanism. Proc. Natl. Acad. Sci. USA 87:9383–9387.
   PubMed Web of Science ®Google Scholar
• Patrono, C., Davi, G., Giabattoni, G. 1992. Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors. Trends Cardiovasc. Med. 2:15–20.
   PubMedGoogle Scholar
• Reilly, M., Delanty, N., Lawson, J., FitzGerald, G.A. 1996. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94:19–25.
   PubMed Web of Science ®Google Scholar
• Stratton, K., Shetty, P., Wallace, R., and Bondurant, S. ( eds.). 2001. Clearing the smoke. Assessing the science base for tobacco harm reduction. Institute of Medicine. Washington, DC: National Academy Press.
   Google Scholar
• Swinscow, S.K.W. 1997. Statistics at Square One, 9th ed ( rev. by M.J. Campbell). London: BMJ Press. Available online at http://www.bmj.com/collections/statsbk/index.dtl [ accessed May 2008].
   Google Scholar
• Their, R., Brüning, T., Kocher, K., Blaszkewicz, M., Makropoulos, V., Sundberg, A., Bolt, H.M. 1999. Determination of urinary thymidine glycol using affinity chromatography, HPLC and post-column reaction detection: A biomarker of oxidative DNA damage upon kidney transplantation. Arch. Toxicol. 73:479–484.
   PubMedGoogle Scholar
• World Health Organisation. World Health Report 2002. Reducing risks, promoting healthy life. Geneva: World Health Organisation.
   Google Scholar
• Zedler, B.K., Kinser, R., Oey, J., Nelson, B., Roethig, H.J., Walk, R.A., Kuhl, P., Rustemeier, K., Schepers, G., Von Holt, K., Tricker, A.R. 2006. Biomarkers of exposure and potential harm in adult smokers of 3–7 mg tar yield (Federal Trade Commission) cigarettes and in adult non-smokers. Biomarkers 11:201–220.
   PubMed Web of Science ®Google Scholar